TEIJIN PHARMA SUES TOWA OVER GENERIC DRUG'S CONTAINER
TWAPF | Quote | Chart | News | PowerRating -- Teijin Pharma Ltd. said Friday
that it has filed suit in the Tokyo District Court against Towa
Pharmaceutical Co. (TSE:4553), alleging that a container design
used by the generic-drug maker are too much like its own.
Towa makes a generic version of Teijin Pharma's Rhinocort
Powder Spray for Nasal Use, a hay fever remedy. Teijin Pharma
accused Towa of engaging in unfair competition because the
shape and dispensing method of the drug's container bear too
close a resemblance to its own, causing Towa's product to be
mistaken for Teijin Pharma's.
The Teijin Ltd. (TSE:3401) subsidiary is asking the court to
order Towa to cease production and sales of the products in
question and is also seeking 8 million yen in damages.
Towa representatives said they could not comment because
they have not yet seen the document.
(Nikkei)
For full details on (TINLY) TINLY. (TINLY) has Short Term PowerRatings at TradingMarkets. Details on (TINLY) Short Term PowerRatings is available at This Link.
For full details on (TWAPF) TWAPF. (TWAPF) has Short Term PowerRatings at TradingMarkets. Details on (TWAPF) Short Term PowerRatings is available at This Link.
- Teijin Limited: Teijin Signs Agreement for SanBio's New Drug for Stroke Therapy - Major Entry into Regenerative Medicine Market - 02/05/10
- TEIJIN UNIT BOOSTING PRODUCTION OF VALUE-ADDED CARBON FIBERS - 01/28/10
- JAPANESE CO TEIJIN SELLS INDONESIAN SUBSIDIARY - 12/21/09
- Universal Display and the Flexible Display Center at ASU Enhance Strategic Relationship to Supply Flexible Active-Matrix PHOLED - 11/19/09
- Remy International, Inc. Announces New Chief Financial Officer - 11/18/09
- More News >>


